Lindy Biosciences
Durham
About Lindy Biosciences
Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2022)
- Website: lindybio.com
- Phone: (919) 748-4480
Industries & Categories
Biotechnology, Product Research, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/lindy-biosciences-26361 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.